Emergence of Bruton's tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemia

Author:

Glavey Siobhan1ORCID,Quinn John1,McCloy Mary2,Sargent Jeremy2,McCartney Yvonne3,Catherwood Mark4,Marafioti Teresa5,Leader Mary3,Murphy Philip1,Thornton Patrick1

Affiliation:

1. Department of Haematology; Beaumont Hospital; Dublin Ireland

2. Department of Haematology; Our Lady of Lourdes Hospital; Drogheda Ireland

3. Department of Histopathology; Beaumont Hospital; Dublin Ireland

4. Department of Haemato-Oncology; Belfast City Hospital; Belfast UK

5. Department of Histopathology; University College Hospital; London UK

Publisher

Wiley

Subject

Hematology,General Medicine

Reference5 articles.

1. Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia;Oscier;Br J Haematol,2012

2. Hodgkin transformation of chronic lymphocytic leukemia: the M D. Anderson Cancer Center experience;Tsimberidou;Cancer,2006

3. Phosphatidylinositol 3-kinase delta blockade increases genomic instability in B cells;Compagno;Nature,2017

4. Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma;Fernandez-Vega;Virchows Arch,2015

5. Ibrutinib in refractory classic Hodgkin's lymphoma;Hamadani;N Engl J Med,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3